English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine MedTech
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area
Oct 21, 2024 10:00 HKT
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China
Sep 24, 2024 21:00 HKT
Taiwan Excellence Pavilion concludes Medical Fair Asia 2024 with Showcase of Cutting-Edge MedTech Innovations
Sep 13, 2024 17:50 HKT
Taiwan Excellence Unveils Pioneering Medtech Innovation at Medical Fair Asia 2024
Sep 05, 2024 23:00 HKT
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Aug 23, 2024 08:00 HKT
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023
Aug 16, 2024 13:00 HKT
An Asian Company Achieves Breakthrough in the Key Technology of Ac-225 Preparation
Aug 15, 2024 20:00 HKT
China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China
Aug 05, 2024 22:00 HKT
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating
Jul 16, 2024 20:00 HKT
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
Jun 25, 2024 20:00 HKT
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
Jun 18, 2024 18:45 HKT
Vinmec's Innovations Spotlighted at Global CSR & ESG Summit 2024
May 09, 2024 05:04 HKT
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
Apr 23, 2024 22:00 HKT
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
Apr 16, 2024 17:04 HKT
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
Apr 01, 2024 20:30 HKT
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs
Mar 28, 2024 10:23 HKT
How AI, Genetics and Biotechnology Revolutions will Transform our Future: Jamie Metzl at the Global AI Show
Mar 25, 2024 07:45 HKT
Avantor Wins Five Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2024
Mar 21, 2024 09:00 HKT
TechInvention Lifecare announces the groundbreaking of its state-of-the-art Global Collaborative Centre for Medical Countermeasures
Feb 28, 2024 09:00 HKT
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R)
Feb 04, 2024 09:00 HKT
Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: